About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 3NCT00975091

Continue Entecavir Rollover From China

The purpose of the study is to determine if treatment with entecavir is safe and well tolerated in patients who completed dosing in a previous entecavir study in China, but are requiring further treat...

Lead sponsor: Bristol-Myers Squibb•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Bristol-Myers Squibb

Age

16 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Subjects who had completed the required dosing period in a previous ETV Phase 2 or 3 study in China (studies AI463012, AI463023, AI463056), and had been assessed by the Investigators as likely to benefit from additional therapy for treatment of their HBV infection
•ALT ≤ 15 x upper limit of normal
•Compensated liver disease

Exclusion Criteria

•Coinfection with HIV, HCV, or HDV

Related studies

New HBV Infection Biomarkers: Clinical Characterization and Impact on Management

NCT06906016 · Chronic Hepatitis B Virus (HBV) Infection

Active Not RecruitingPhase 2

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial to Evaluate the Efficacy and Safety of TVAX-008 Injection in Treated Patients With Chronic Hepatitis B

NCT07190742 · Chronic Hepatitis B Virus

Active Not RecruitingPhase 2

A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

NCT06537414 · Chronic Hepatitis B Virus Infection, Hepatitis B

Active Not RecruitingPhase 2

Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and PEG-IFNα Treating Chronic Hepatitis B Virus (HBV) Infection (ENRICH)

NCT06491563 · For Treatment of Chronic Hepatitis B Virus Infection

Not Yet RecruitingPhase 2

Clinical Study to Evaluate the Efficacy and Safety of HH-006 in Patients With Chronic Hepatitis B Virus Infection

NCT07519330 · Chronic Hepatitis B Virus Infection

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 2, 2010Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE3

Enrollment600

Start dateMay 2004

Last updatedFeb 2, 2010

Condition

Chronic Hepatitis B Virus

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2010Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions